200
Participants
Start Date
December 31, 2016
Primary Completion Date
December 31, 2022
Study Completion Date
June 30, 2023
Bivigam
Human immune globulin
Other
Human immune globulin
The Center for Allergy, Asthma & Immunology, Syosset
Lysosomal Rare Disorders Research & Treatment Center, Fairfax
Allergy Asthma & Immunology Relief, Charlotte
Central Georgia Infectious Disease Consultants, Macon
Ohio Clinical Research Associates, Mayfield Heights
Midwest Allergy and Sinus, Normal
Kanarek Adult & Pediatric Allergy & Immunology, Overland Park
Infectious Disease Consultants, Wichita
Oklahoma Institute of Allergy and Asthma Clinical Research, Oklahoma City
Discovery Clinical Trials, Dallas
Allergy Partners of North Texas, Dallas
Allergy Immunology and Respiratory Care, Dallas
University of Texas Southwestern Medical Center, Irving
Austin Infectious Disease Consultants, Austin
Immunoe Research Centers, Centennial
Santa Barbara Specialty Pharmacy, Carpinteria
Allergy and Asthma of the Bay Area, Walnut Creek
Lead Sponsor
ADMA Biologics, Inc.
INDUSTRY